{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T14:13:41Z","timestamp":1765289621363,"version":"3.46.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1245\/s10434-025-18437-9","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T19:13:31Z","timestamp":1761333211000},"page":"561-567","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Transplant Oncology\u2014A New Frontier in Liver Cancer Care"],"prefix":"10.1245","volume":"33","author":[{"given":"Lavanya","family":"Yohanathan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Talia","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"key":"18437_CR1","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1053\/jlts.2002.34892","volume":"8","author":"FY Yao","year":"2002","unstructured":"Yao FY, Ferrell L, Bass NM, Bacchetti P, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl. 2002;8:765\u201374. https:\/\/doi.org\/10.1053\/jlts.2002.34892.","journal-title":"Liver Transpl"},{"key":"18437_CR2","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1002\/hep.28643","volume":"64","author":"G Sapisochin","year":"2016","unstructured":"Sapisochin G, Goldaracena N, Laurence JM, Dib M, Barbas A, Ghanekar A. The extended Toronto criteria for liver transplantation in patients with hepatocellular carcinoma: a prospective validation study. Hepatology. 2016;64:2077\u201388. https:\/\/doi.org\/10.1002\/hep.28643.","journal-title":"Hepatology"},{"issue":"2","key":"18437_CR3","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.surg.2018.10.024","volume":"165","author":"T Hib","year":"2019","unstructured":"Hib T, Sapisochin G. What is transplant oncology? Surgery. 2019;165(2):281\u20135. https:\/\/doi.org\/10.1016\/j.surg.2018.10.024.","journal-title":"Surgery"},{"key":"18437_CR4","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMra1713263","volume":"380","author":"A Villanueva","year":"2019","unstructured":"Villanueva A. Hepatocellular carcinoma. N Engl J Med. 2019;380:1450\u201362.","journal-title":"N Engl J Med"},{"key":"18437_CR5","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","volume":"383","author":"N Razumilava","year":"2014","unstructured":"Razumilava N, Gores GJ. Cholangiocarcinoma. Lancet. 2014;383:2168\u201379.","journal-title":"Lancet"},{"key":"18437_CR6","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.jhep.2014.01.021","volume":"60","author":"J Bridgewater","year":"2014","unstructured":"Bridgewater J, Galle PR, Khan SA, Llovet JM, Park JW, Patel T, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol. 2014;60:1268\u201389.","journal-title":"J Hepatol"},{"key":"18437_CR7","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1046\/j.1365-2168.2000.01532.x","volume":"87","author":"A Weimann","year":"2000","unstructured":"Weimann A, Varnholt H, Schlitt HJ, Lang H, Flemming P, Hustedt C, et al. Retrospective analysis of prognostic factors after liver resection and transplantation for cholangiocellular carcinoma. Br J Surg. 2000;87:1182\u20137.","journal-title":"Br J Surg"},{"key":"18437_CR8","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1053\/jlts.2001.29419","volume":"7","author":"M Shimoda","year":"2001","unstructured":"Shimoda M, Farmer DG, Colquhoun SD, Rosove M, Ghobrial RM, Yersiz H, et al. Liver transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature. Liver Transpl. 2001;7:1023\u201333.","journal-title":"Liver Transpl"},{"key":"18437_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/01.sla.0000108702.45715.81","volume":"239","author":"R Robles","year":"2004","unstructured":"Robles R, Figueras J, Turri\u00f3n VS, Margarit C, Moya A, Varo E, et al. Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma. Ann Surg. 2004;239:265\u201371.","journal-title":"Ann Surg"},{"key":"18437_CR10","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1159\/000332827","volume":"47","author":"BS Fu","year":"2011","unstructured":"Fu BS, Zhang T, Li H, Yi SH, Wang GS, Xu C, et al. The role of liver transplantation for intrahepatic cholangiocarcinoma: a single-center experience. Eur Surg Res. 2011;47:218\u201321.","journal-title":"Eur Surg Res"},{"issue":"4","key":"18437_CR11","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1002\/hep.28744","volume":"64","author":"G Sapisochin","year":"2016","unstructured":"Sapisochin G, Facciuto M, Rubbia-Brandt L, Marti J, Mehta N, Yao FY, et al. Liver transplantation for \u201cvery early\u201d intrahepatic cholangiocarcinoma: international retrospective study supporting a prospective assessment. Hepatology. 2016;64(4):1178\u201388. https:\/\/doi.org\/10.1002\/hep.28744.","journal-title":"Hepatology"},{"issue":"3","key":"18437_CR12","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/ctr.12108","volume":"27","author":"M Vallin","year":"2013","unstructured":"Vallin M, Sturm N, Lamblin G, Guillaud O, Hilleret MN, Hervieu V, et al. Unrecognized intrahepatic cholangiocarcinoma: an analysis of 993 adult cirrhotic liver explants. Clin Transplant. 2013;27(3):403\u20139. https:\/\/doi.org\/10.1111\/ctr.12108.","journal-title":"Clin Transplant"},{"key":"18437_CR13","doi-asserted-by":"publisher","first-page":"208","DOI":"10.12659\/aot.895936","volume":"21","author":"K Takahashi","year":"2016","unstructured":"Takahashi K, Obeid J, Burmeister CS, Bruno DA, Kazimi MM, Yoshida A, et al. Intrahepatic cholangiocarcinoma in the liver explant after liver transplantation: histological differentiation and prognosis. Ann Transplant. 2016;21:208\u201315. https:\/\/doi.org\/10.12659\/aot.895936.","journal-title":"Ann Transplant"},{"issue":"3","key":"18437_CR14","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/ajt.16906","volume":"22","author":"RR McMillan","year":"2022","unstructured":"McMillan RR, Javle M, Kodali S, Saharia A, Mobley C, Heyne K, et al. Survival following liver transplantation for locally advanced, unresectable intrahepatic cholangiocarcinoma. Am J Transplant. 2022;22(3):823\u201332.","journal-title":"Am J Transplant"},{"issue":"6","key":"18437_CR15","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/archsurg.2011.116","volume":"146","author":"JC Hong","year":"2011","unstructured":"Hong JC, Jones CM, Duffy JP, Petrowsky H, Farmer DG, French S, Finn R, Durazo FA, Saab S, Tong MJ, Hiatt JR, Busuttil RW. Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma: a 24-year experience in a single center. Arch Surg. 2011;146(6):683\u20139. https:\/\/doi.org\/10.1001\/archsurg.2011.116.","journal-title":"Arch Surg"},{"issue":"5","key":"18437_CR16","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S2468-1253(18)30045-1","volume":"3","author":"KE Lunsford","year":"2018","unstructured":"Lunsford KE, Javle M, Heyne K, Shroff RT, Abdel-Wahab R, Gupta N, et al. Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series. Lancet Gastroenterol Hepatol. 2018;3(5):337\u201348.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"18437_CR17","unstructured":"Organ Procurement and Transplantation Network. Notice of OPTN policy and guidance changes. OPTN. 2024. https:\/\/optn.transplant.hrsa.gov\/media\/ymapp25j\/liver_nlrb_june-2024_pn.pdf."},{"key":"18437_CR18","unstructured":"Organ Procurement & Transplant Network. US Department of Health & Human Services. https:\/\/optn.transplant.hrsa.gov."},{"key":"18437_CR19","doi-asserted-by":"publisher","first-page":"LBA3","DOI":"10.1200\/jco.2014.32.18_suppl.lba3","volume":"32","author":"AP Venook","year":"2014","unstructured":"Venook AP, Niedzwiecki D, Lenz HJ, Innocenti F, Mahoney MR, O\u2019Neil BH, et al. CALGB\/SWOG 80405: phase III trial of irinotecan\/5-FU\/leucovorin (FOLFIRI) or oxaliplatin\/5-FU\/leucovorin (mFOLFOX6) with bevacizumab (BV) or cetuximab (CET) for patients (pts) with KRAS wild-type (wt) untreated metastatic adenocarcinoma of the colon or re. J Clin Oncol. 2014;32:LBA3.","journal-title":"J Clin Oncol"},{"key":"18437_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/jnci\/djq456","volume":"103","author":"G Masi","year":"2011","unstructured":"Masi G, Vasile E, Loupakis F, Cupini S, Fornaro L, Baldi G, et al. Randomized trial of two induction chemotherapy regimens in metastatic colorectal cancer: an updated analysis. J Natl Cancer Inst. 2011;103:21\u201330.","journal-title":"J Natl Cancer Inst"},{"key":"18437_CR21","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/ags3.12227","volume":"3","author":"R Adam","year":"2019","unstructured":"Adam R, Kitano Y. Multidisciplinary approach of liver metastases from colorectal cancer. Ann Gastroenterol Surg. 2019;3:50\u20136.","journal-title":"Ann Gastroenterol Surg"},{"issue":"11","key":"18437_CR22","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1097\/LVT.0000000000000397","volume":"30","author":"N Goldaracena","year":"2024","unstructured":"Goldaracena N, Zhu A, Vargas PA, Karanicolas P, Henry Z, Sayed B, et al. Hepatic artery infusion pump for unresectable colorectal liver metastases before living donor liver transplant: oncological friend or technical foe? Liver Transplant. 2024;30(11):1203\u20137.","journal-title":"Liver Transplant"},{"issue":"1","key":"18437_CR23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.yao.2024.11.002","volume":"5","author":"LM Janczewski","year":"2025","unstructured":"Janczewski LM, Merkow RP. Hepatic artery infusion pump therapy in unresectable and resectable liver tumors. Adv Oncol. 2025;5(1):35\u201342.","journal-title":"Adv Oncol"},{"key":"18437_CR24","doi-asserted-by":"crossref","unstructured":"Meijerink MR, van der Lei S, Dijkstra M, Versteeg KS, Buffart TE, Lissenberg-Witte BI, COLLISION Trial Collaborator Group. Surgery versus thermal ablation for small-size colorectal liver metastases (COLLISION): An international, multicenter, phase III randomized controlled trial. 2024.","DOI":"10.1200\/JCO.2024.42.17_suppl.LBA3501"},{"key":"18437_CR25","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","volume":"394","author":"E Dekker","year":"2019","unstructured":"Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB. Colorectal cancer. Lancet. 2019;394:1467\u201380.","journal-title":"Lancet"},{"key":"18437_CR26","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1097\/SLA.0b013e3182823957","volume":"257","author":"M Hagness","year":"2013","unstructured":"Hagness M, Foss A, Line PD, et al. Liver transplantation for nonresectable liver metastases from colorectal cancer. Ann Surg. 2013;257:800\u20136.","journal-title":"Ann Surg"},{"key":"18437_CR27","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1002\/lt.24791","volume":"23","author":"C Toso","year":"2017","unstructured":"Toso C, Pinto Marques H, Andres A, et al. Liver transplantation for colorectal liver metastasis: survival without recurrence can be achieved. Liver Transpl. 2017;23:1073\u20136.","journal-title":"Liver Transpl"},{"issue":"2","key":"18437_CR28","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/SLA.0000000000003404","volume":"271","author":"S Dueland","year":"2020","unstructured":"Dueland S, Syversveen T, Solheim JM, Solberg S, Grut H, Bj\u00f8rnbeth BA, Line P. Survival following liver transplantation for patients with nonresectable liver-only colorectal metastases. Ann Surg. 2020;271(2):212\u20138.","journal-title":"Ann Surg"},{"issue":"10458","key":"18437_CR29","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/S0140-6736(24)01595-2","volume":"404","author":"R Adam","year":"2024","unstructured":"Adam R, Piedvache C, Chiche L, Adam JP, Salam\u00e9 E, Bucur P, et al. Liver transplantation plus chemotherapy versus chemotherapy alone in patients with permanently unresectable colorectal liver metastases (TransMet): results from a multicentre, open-label, prospective, randomised controlled trial. Lancet. 2024;404(10458):1107\u201318.","journal-title":"Lancet"},{"key":"18437_CR30","doi-asserted-by":"publisher","first-page":"102608","DOI":"10.1016\/j.eclinm.2024.102608","volume":"72","author":"R Adam","year":"2024","unstructured":"Adam R, Badrudin D, Chiche L, Bucur P, Scatton O, Granger V, et al. Safety and feasibility of chemotherapy followed by liver transplantation for patients with definitely unresectable colorectal liver metastases: insights from the TransMet randomised clinical trial. EClinicalMedicine. 2024;72:102608. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102608.","journal-title":"EClinicalMedicine"},{"key":"18437_CR31","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1001\/jamaoncol.2019.3616","volume":"5","author":"J Tie","year":"2019","unstructured":"Tie J, Cohen JD, Wang Y, Christie M, Simons K, Lee M, et al. Circulating tumor DNA analyses as markers of recurrence risk and benefit of adjuvant therapy for stage III colon cancer. JAMA Oncol. 2019;5:1710\u20137.","journal-title":"JAMA Oncol"},{"key":"18437_CR32","doi-asserted-by":"publisher","first-page":"346ra92","DOI":"10.1126\/scitranslmed.aaf6219","volume":"8","author":"J Tie","year":"2016","unstructured":"Tie J, Wang Y, Tomasetti C, Li L, Springer S, Kinde I, et al. Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer. Sci Transl Med. 2016;8:346ra92.","journal-title":"Sci Transl Med"},{"key":"18437_CR33","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1001\/jamaoncol.2019.0528","volume":"5","author":"T Reinert","year":"2019","unstructured":"Reinert T, Henriksen TV, Christensen E, Sharma S, Salari R, Sethi H, et al. Analysis of plasma cell-free DNA by ultradeep sequencing in patients with stages I\u2013III colorectal cancer. JAMA Oncol. 2019;5:1124\u201331.","journal-title":"JAMA Oncol"},{"key":"18437_CR34","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1002\/cncr.30254","volume":"122","author":"M Javle","year":"2016","unstructured":"Javle M, Bekaii-Saab T, Jain A, et al. Biliary cancer: utility of next-generation sequencing for clinical management. Cancer. 2016;122:3838\u201347.","journal-title":"Cancer"},{"issue":"11","key":"18437_CR35","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1097\/TP.0000000000000723","volume":"99","author":"YR Nobel","year":"2015","unstructured":"Nobel YR, Goldberg DS. Variable use of model for end-stage liver disease exception points in patients with neuroendocrine tumors metastatic to the liver and its impact on patient outcomes. Transplantation. 2015;99(11):2341\u20136. https:\/\/doi.org\/10.1097\/TP.0000000000000723.","journal-title":"Transplantation"},{"key":"18437_CR36","unstructured":"American Registry for Transplant Oncology (ARTx-Onc)\u2014UR Medicine.\u00a0https:\/\/www.urmc.rochester.edu\/surgery\/research\/american-registry-for-transplant-oncology."},{"key":"18437_CR37","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJM199603143341104","volume":"334","author":"V Mazzaferro","year":"1996","unstructured":"Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693\u20139.","journal-title":"N Engl J Med"},{"key":"18437_CR38","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2147\/JHC.S61146","volume":"3","author":"J Balogh","year":"2016","unstructured":"Balogh J, Victor D 3rd, Asham EH, Burroughs SG, Boktour M, Saharia A. Hepatocellular carcinoma: a review. J Hepatocell Carcinoma. 2016;3:41\u201353. https:\/\/doi.org\/10.2147\/JHC.S61146.","journal-title":"J Hepatocell Carcinoma"},{"key":"18437_CR39","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/SLA.0000000000002477","volume":"267","author":"X Muller","year":"2018","unstructured":"Muller X, Marcon F, Sapisochin G, et al. Defining benchmarks in liver transplantation: a multicenter outcome analysis determining best achievable results. Ann Surg. 2018;267:419\u201325.","journal-title":"Ann Surg"},{"key":"18437_CR40","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.jhep.2018.12.029","volume":"70","author":"N Goldaracena","year":"2019","unstructured":"Goldaracena N, Gorgen A, Doyle A, et al. Live donor liver transplantation for patients with hepatocellular carcinoma offers increased survival vs. deceased donation. J Hepatol. 2019;70:666\u201373.","journal-title":"J Hepatol"},{"key":"18437_CR41","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/lt.25068","volume":"24","author":"D Kollmann","year":"2018","unstructured":"Kollmann D, Sapisochin G, Goldaracena N, et al. Expanding the donor pool: donation after circulatory death and living liver donation do not compromise the results of liver transplantation. Liver Transpl. 2018;24:779\u201389.","journal-title":"Liver Transpl"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18437-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-18437-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18437-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T14:09:26Z","timestamp":1765289366000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-18437-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["18437"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-18437-9","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"type":"print","value":"1068-9265"},{"type":"electronic","value":"1534-4681"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"27 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}